Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men (Cochrane Review)

A substantive amendment to this systematic review was last made on 07 May 2002. Cochrane reviews are regularly checked and updated if necessary.

Background: There is a need for female-controlled methods of HIV prevention. Vaginal microbicides, substances inserted into the vagina to prevent women acquiring HIV and sexually transmitted infections (STIs) from men, could be useful in this regard. One potential vaginal microbicide is the widely used spermicide, nonoxynol-9 (N-9).

Objectives: To determine the safety and effectiveness of N-9 in preventing vaginal acquisition of HIV infection by women from men.

Search strategy: Extensive searches of electronic databases, conference abstracts, reference lists of relevant studies and contact with experts and funders.

Selection criteria: Randomised controlled trials meeting pre-determined quality criteria with HIV infection as the outcome.

Data collection and analysis: Data were extracted by one reviewer and checked by the another. Any discrepancies were adjudicated by a third reviewer.

Main results: Five trials were included in the review and four contributed to a meta-analysis. Overall, the risk of HIV infection was not statistically significantly different among women receiving N-9 (relative risk [RR] 1.12, 95% CI 0.88-1.42; p=0.4). The risk of genital lesions was statistically significantly greater among women receiving N-9 (RR 1.18, 95%CI 1.02-1.36; p=0.02).

Reviewers' conclusions: There is no evidence that nonoxynol-9 protects against vaginal acquisition of HIV infection by women from men. There is evidence that it may do harm by increasing the frequency of genital lesions.

Citation: Wilkinson D, Ramjee G, Tholandi M, Rutherford G.. Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.

---

This is an abstract of a regularly updated, systematic review prepared and maintained by the Cochrane Collaboration. The full text of the review is available in The Cochrane Library (ISSN 1464-780X).

The Cochrane Library is designed and produced by Update Software Ltd.

Update Software Ltd, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK
(Tel:+44 1865 513902; Fax:+44 1865 516918)

File Reference: AB003936.htm